Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICAC: Preemptive MRD Management in CLL Transplant
NCT01849939Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Sep 2012
- Primary completion
- Sep 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocytes in chronic lymphocytic leukemia (CLL), B-cell chronic lymphocytic leukemia (B-CLL), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
donor lymphocytes
03
Conditions
chronic lymphocytic leukemia (CLL)B-cell chronic lymphocytic leukemia (B-CLL)
Beyond the preview
Go deeper on NCT01849939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849939.